-
1
المؤلفون: Jørgen Vestbo, Wim Janssens, Chaicharn Pothirat, Sibel Naycı, Adam Antczak, Dinesh Saralaya, Uffe Bodtger, Nicolas Roche, Gaëtan DESLEE, Stephen Field, Miodrag Vukcevic, Nicolino Ambrosino
المساهمون: Janssens, Wim, Laboratoire de Mécanique, Modélisation et Procédés Propres (M2P2), Centre National de la Recherche Scientifique (CNRS)-École Centrale de Marseille (ECM)-Aix Marseille Université (AMU), Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Aix Marseille Université (AMU)-École Centrale de Marseille (ECM)-Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Clinical sciences, Rehabilitation Research
المصدر: New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2016, 374 (23), pp.2222-2234. ⟨10.1056/NEJMoa1516385⟩
New England Journal of Medicine, 2016, 374 (23), pp.2222-2234. ⟨10.1056/NEJMoa1516385⟩
FLAME Investigators & Bødtger, U 2016, ' Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD ', The New England Journal of Medicine, vol. 374, no. 23, pp. 2222-2234 . https://doi.org/10.1056/NEJMoa1516385مصطلحات موضوعية: Glucocorticoids/therapeutic use, Male, Exacerbation, Fluticasone-Salmeterol Drug Combination/adverse effects, Quinolones, Muscarinic Antagonists/therapeutic use, law.invention, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Randomized controlled trial, law, Adrenergic beta-2 Receptor Agonists/therapeutic use, 030212 general & internal medicine, ComputingMilieux_MISCELLANEOUS, Fluticasone, Medicine(all), COPD, Glycopyrrolate/adverse effects, General Medicine, Middle Aged, Pulmonary Disease, Chronic Obstructive/drug therapy, 3. Good health, Drug Combinations, Anesthesia, Indans, Female, Salmeterol, hormones, hormone substitutes, and hormone antagonists, medicine.drug, Indans/adverse effects, Muscarinic Antagonists, 03 medical and health sciences, QUINOLONES, Double-Blind Method, Administration, Inhalation, medicine, Humans, Adrenergic beta-2 Receptor Agonists, Glucocorticoids, Aged, Fluticasone-Salmeterol Drug Combination, Quinolones/adverse effects, business.industry, medicine.disease, Glycopyrrolate, Regimen, 030228 respiratory system, Fluticasone Propionate, Salmeterol Xinafoate Drug Combination, Indacaterol, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
وصف الملف: Print-Electronic; application/pdf
